Manufacturing and Supply Agreement:
Peptisyntha for Helix BioMedix, Inc.
This Manufacturing and Supply Agreement (the “ Agreement ”) is made as of January 9, 2008 (the “ Effective Date ”) by and
between Helix BioMedix, Inc., a Delaware corporation, its principal offices being located at 22118 20th Ave. SE, Suite 204,
Bothell, WA 98021 (“ Helix ”) and Peptisyntha, Inc., a Delaware corporation, its principal offices being located at 20910 Higgins
Court, Torrance, CA 90501 (“ Peptisyntha ”).
In consideration of the mutual covenants, promises, and conditions set forth below, the parties, intending to be bound, agree as
Confidential treatment has been requested for portions of Exhibit A. This exhibit omits the information subject to the
confidential treatment request. Omissions are designated as ***. A complete version of this exhibit has been filed separately
with the Securities and Exchange Commission.
1. Definitions . The following capitalized terms when used in this Agreement shall have the respective meanings set forth
“ Bill of Material ” shall mean any materials and components lists and related instructions and information provided
by Helix to Peptisyntha and concerning components required or preferred for the manufacture of a Peptide by
Peptisyntha pursuant to this Agreement.
“ Disclosing Party ” shall have the meaning stated in Section 10 hereof.
“ Effective Date ” shall have the meaning stated in the preamble of this Agreement.
“ Intellectual Property ” shall mean trade secrets, ideas, inventions, designs, developments, devices, methods or
processes (whether patented or able to be patented and whether or not reduced to practice) and all patents and
patent applications related thereto; copyrightable works and mask works (whether or not registered); trademarks,
service marks and trade dress; and all registrations and applications for registration related thereto; and all